Aptevo Therapeutics Gross Margin Growth & History (APVO)

Aptevo Therapeutics's gross margin was 38.54% for fiscal 2019.

View full Aptevo Therapeutics company overview

Aptevo Therapeutics annual gross margin history

Aptevo Therapeutics annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20192019-12-3138.54%−12.84 pp
20182018-12-3151.39%−14.44 pp
20172017-12-3165.82%+90.68 pp
20162016-12-31−24.86%−74.46 pp
20152015-12-3149.61%

Aptevo Therapeutics gross margin trends

Between the periods ended 2015-12-31 and 2019-12-31, Aptevo Therapeutics's gross margin decreased from 49.61% to 38.54%, a change of −11.06 percentage points. The latest reported quarter, Q4 2019, shows 32.06%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Aptevo Therapeutics source filings ↗

Community posts

It’s quiet here.

No posts about APVO yet. Start the conversation.

Write the first post